Found: 39
Select item for more details and to access through your institution.
Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1198, doi. 10.1007/s10637-019-00736-0
- By:
- Publication type:
- Article
High Expression of Major Histocompatibility Complex Class I in Clear Cell Renal Cell Carcinoma Is Associated with Improved Prognosis.
- Published in:
- Urologia Internationalis, 2015, v. 95, n. 1, p. 72, doi. 10.1159/000370164
- By:
- Publication type:
- Article
Understanding the Impact of ErbB Activating Events and Signal Transduction on Antigen Processing and Presentation: MHC Expression as a Model.
- Published in:
- Frontiers in Pharmacology, 2016, p. 8, doi. 10.3389/fphar.2016.00327
- By:
- Publication type:
- Article
Neoadjuvant Cabozantinib in an Unresectable Locally Advanced Renal Cell Carcinoma Patient Leads to Downsizing of Tumor Enabling Surgical Resection: A Case Report.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.622134
- By:
- Publication type:
- Article
NAD<sup>+</sup> protects against EAE by regulating CD4<sup>+</sup> T-cell differentiation.
- Published in:
- Nature Communications, 2014, v. 5, n. 10, p. 5101, doi. 10.1038/ncomms6101
- By:
- Publication type:
- Article
Blockade of immune checkpoints in lymph nodes through locoregional delivery augments cancer immunotherapy.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 563, p. 1, doi. 10.1126/scitranslmed.aay3575
- By:
- Publication type:
- Article
Expression of novel long noncoding RNAs defines virus-specific effector and memory CD8<sup>+</sup> T cells.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-018-07956-7
- By:
- Publication type:
- Article
Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1072, doi. 10.1093/oncolo/oyad154
- By:
- Publication type:
- Article
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2021, v. 26, n. 12, p. 1017, doi. 10.1002/onco.13922
- By:
- Publication type:
- Article
Immune‐Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1742, doi. 10.1002/onco.13868
- By:
- Publication type:
- Article
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 397, doi. 10.1002/onco.13727
- By:
- Publication type:
- Article
Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e484, doi. 10.1634/theoncologist.2019-0578
- By:
- Publication type:
- Article
Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e528, doi. 10.1634/theoncologist.2019-0751
- By:
- Publication type:
- Article
Extracellular vesicles from bone marrow-derived mesenchymal stromal cells support ex vivo survival of human antibody secreting cells.
- Published in:
- Journal of Extracellular Vesicles, 2018, v. 7, n. 1, p. 1, doi. 10.1080/20013078.2018.1463778
- By:
- Publication type:
- Article
Extracellular vesicles from bone marrow-derived mesenchymal stromal cells support ex vivo survival of human antibody secreting cells.
- Published in:
- Journal of Extracellular Vesicles, 2018, v. 7, n. 1, p. 1, doi. 10.1080/20013078.2018.1463778
- By:
- Publication type:
- Article
Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 8, p. 2752, doi. 10.1002/cam4.2932
- By:
- Publication type:
- Article
Case Report: Exceptional response to nivolumab plus cabozantinib in a patient with extrarenal clear cell renal cell carcinoma.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1271255
- By:
- Publication type:
- Article
The Scavenger Receptor MARCO Modulates TLR-Induced Responses in Dendritic Cells.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0104148
- By:
- Publication type:
- Article
Immunization with a Peptide Containing MHC Class I and II Epitopes Derived from the Tumor Antigen SIM2 Induces an Effective CD4 and CD8 T-Cell Response.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0093231
- By:
- Publication type:
- Article
Sarcopenia and systemic inflammation are associated with decreased survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 11, p. 2073, doi. 10.1002/cncr.34174
- By:
- Publication type:
- Article
Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Reply to Tumor-associated macrophages: "Good cop-bad cop".
- Published in:
- 2019
- By:
- Publication type:
- letter
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Organized immune cell interactions within tumors sustain a productive T-cell response.
- Published in:
- International Immunology, 2021, v. 33, n. 1, p. 27, doi. 10.1093/intimm/dxaa057
- By:
- Publication type:
- Article
Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34242-4
- By:
- Publication type:
- Article
Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer.
- Published in:
- Journal of Clinical Pharmacology, 2018, v. 58, n. 1, p. 7, doi. 10.1002/jcph.1028
- By:
- Publication type:
- Article
Tumour eradication and induction of memory against murine mesothelioma by combined immunotherapy.
- Published in:
- Immunology & Cell Biology, 2012, v. 90, n. 8, p. 822, doi. 10.1038/icb.2012.2
- By:
- Publication type:
- Article
Invariant NKT cell-augmented GM-CSF-secreting tumor vaccine is effective in advanced prostate cancer model.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 12, p. 2943, doi. 10.1007/s00262-022-03210-8
- By:
- Publication type:
- Article
Development of a peptide-based vaccine targeting TMPRSS2:ERG fusion-positive prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 12, p. 1831, doi. 10.1007/s00262-013-1482-y
- By:
- Publication type:
- Article
Case Report: Exceptional Response to Nivolumab Plus Ipilimumab in a Young Woman With TFE3-SFPQ Fusion Translocation-Associated Renal Cell Carcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.793808
- By:
- Publication type:
- Article
The transcription factor ERG increases expression of neurotransmitter receptors on prostate cancer cells.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1612-3
- By:
- Publication type:
- Article
The transcription factor ERG increases expression of neurotransmitter receptors on prostate cancer cells.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 604, doi. 10.1186/s12885-015-1612-3
- By:
- Publication type:
- Article
The transcription factor ERG increases expression of neurotransmitter receptors on prostate cancer cells.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Inhibition of established subcutaneous murine tumour growth with topical Melaleuca alternifolia (tea tree) oil.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1095, doi. 10.1007/s00280-010-1267-3
- By:
- Publication type:
- Article
DYNAMICS AND ROLE OF TOX+ TCF1+ CD39+ CD8 T CELLS IN LYMPHOID TISSUE IN SIV INFECTION.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 131
- By:
- Publication type:
- Article
An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets.
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0465-4
- By:
- Publication type:
- Article
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Beyond immune checkpoint blockade: New approaches to targeting host-tumor interactions in prostate cancer: Report from the 2014 Coffey-Holden prostate cancer Academy meeting.
- Published in:
- Prostate, 2015, v. 75, n. 4, p. 337, doi. 10.1002/pros.22920
- By:
- Publication type:
- Article
CMV Status Drives Distinct Trajectories of CD4+ T Cell Differentiation.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.620386
- By:
- Publication type:
- Article